sfk
result
identifi
new
role
csk
flaviviru
replic
enhanc
understand
viral
replic
provid
new
drug
target
antivir
develop
dengu
viru
denv
mosquitoborn
flaviviru
estim
infect
million
peopl
global
infect
exhibit
diseas
symptom
year
dengu
diseas
manifest
wide
spectrum
symptom
mild
dengu
fever
sever
hemorrhag
form
known
dengu
hemorrhag
fever
dhf
dengu
shock
syndrom
dss
addit
antivir
target
viral
protein
directli
identifi
host
factor
requir
viru
life
cycl
provid
addit
target
drug
develop
altern
plausibl
approach
counteract
viral
infect
denv
singl
posit
strand
kb
rna
viru
encod
singl
polyprotein
undergo
cleavag
host
viral
proteas
form
three
structur
proteinscapsid
c
precursormembranemembran
prmm
envelop
e
seven
nonstructur
protein
structur
protein
constitut
viru
particl
ns
protein
involv
viral
rna
replic
viru
assembl
modul
host
cell
respons
tyrosin
kinas
tk
compris
receptor
tyrosin
kinas
rtk
cytosol
tyrosin
kinas
regul
divers
rang
cellular
process
cell
divis
apoptosi
human
genom
encod
tk
rtk
act
growth
factor
receptor
cytosol
tk
particip
intracellular
signal
bind
protein
respons
extrins
intrins
signal
structur
function
mani
tk
well
conserv
across
differ
speci
therefor
mani
pathogen
evolv
util
function
host
tk
variou
stage
infect
thu
provid
opportun
use
host
tk
antivir
target
drug
target
host
tk
commerci
use
condit
acut
myeloid
leukemia
nonsmallcel
lung
cancer
ovarian
cancer
tk
shown
involv
variou
stage
viral
lifecycl
exampl
axl
receptor
tyrosin
kinas
shown
mediat
entri
filovirus
epiderm
growth
factor
receptor
egfr
shown
mediat
hepat
c
viru
entri
regul
receptorcoreceptor
interact
sirna
screen
inhibitor
studi
identifi
receptor
tyrosin
kinas
influenza
viru
entri
replic
studi
screen
sirna
librari
target
human
tyrosin
kinas
identifi
tk
necessari
infect
denv
cell
identifi
tk
either
inhibit
enhanc
denv
infect
vitro
character
one
inhibitor
csk
ctermin
src
kinas
show
csk
activ
requir
denv
replic
effect
mediat
via
regul
src
famili
kinas
identifi
human
tk
involv
dengu
viru
infect
use
sirna
librari
target
human
tk
cell
transfect
sirna
h
posttransfect
cell
infect
moi
cultur
supernat
collect
infect
cell
h
postinfect
pi
viral
titer
measur
plaqu
assay
sirna
either
inhibit
viral
titer
enhanc
infect
twofold
rel
nontarget
control
sirna
consid
hit
see
supplementari
fig
exclud
sirna
affect
cell
viabil
identifi
five
tk
name
ctermin
src
kinas
csk
ephrin
type
b
insulin
receptor
insr
protein
tyrosin
kinas
protein
tyrosin
kinas
caus
reduct
denv
titer
cultur
supernat
without
cytotox
three
tk
discoidin
domain
receptor
tyrosin
kinas
discoidin
domain
receptor
tyrosin
kinas
avian
erythroblast
leukemia
viral
oncogen
homolog
caus
increas
viral
titer
supernat
fig
b
found
target
csk
consist
inhibit
denv
titer
either
smartpool
sirna
fig
least
two
differ
sirna
use
knockdown
fig
therefor
experi
focus
character
role
csk
denv
lifecycl
csk
involv
perform
knockdown
experi
csk
sirna
cell
lysat
total
rna
prepar
denvinfect
cell
found
lower
level
denv
capsid
express
cell
reduc
csk
express
indic
csk
inhibit
denv
lifecycl
stage
prior
viral
protein
translat
fig
measur
denv
rna
level
rtpcr
found
cell
transfect
sicsk
reduct
amount
denv
rna
compar
control
sirna
fig
confirm
whether
celltyp
specif
effect
perform
knockdown
experi
cell
show
reduc
csk
express
cell
effect
denv
titer
observ
cell
see
supplementari
fig
next
valid
observ
perform
experi
two
individu
sirna
smartpool
csk
found
sirna
significantli
reduc
csk
express
level
abl
suppress
product
infecti
viru
inhibit
viral
rna
replic
fig
c
indic
inhibit
viral
replic
link
csk
knockdown
due
offtarget
effect
smartpool
sirna
verifi
observ
effect
csk
knockdown
specif
denv
infect
sirnatransfect
cell
anoth
close
relat
flaviviru
japanes
enceph
viru
jev
measur
viral
titer
supernat
plaqu
assay
viral
rna
level
cell
rtpcr
csk
knockdown
show
similar
effect
jev
infect
viral
titer
viral
rna
level
significantli
reduc
cell
transfect
csk
sirna
fig
verifi
observ
inhibit
result
reduc
cell
prolifer
due
sirna
treatment
fig
next
perform
viru
intern
assay
cell
treat
nontarget
control
ntc
csk
sirna
found
differ
amount
viru
particl
enter
cell
suggest
effect
csk
knockdown
stage
postvir
entri
see
supplementari
fig
next
treat
cell
csk
inhibitor
asn
follow
infect
denv
viral
titer
viral
rna
level
measur
describ
found
inhibit
csk
use
specif
inhibitor
similar
effect
suppress
csk
express
sirna
viral
titer
viral
rna
level
significantli
reduc
cell
treat
csk
inhibitor
compar
mocktreat
cell
fig
g
result
suggest
csk
play
role
stage
viral
rna
replic
flaviviru
lifecycl
next
perform
immunofluoresc
analysi
studi
local
csk
denvinfect
cell
cell
infect
cell
fix
stain
csk
dsrna
h
pi
found
csk
uniformli
distribut
cytosol
discret
membran
compart
pattern
local
csk
similar
mockand
inset
show
western
blot
analysi
csk
knockdown
effici
cell
lysat
h
posttransfect
actin
level
shown
load
control
c
rtpcr
analysi
measur
denv
rna
jev
rna
total
rna
isol
h
pi
cell
transfect
sirna
infect
jev
describ
data
three
experi
perform
two
replic
indic
mean
sem
p
valu
calcul
one
way
anova
use
nonparametr
kruskalw
test
e
cell
transfect
sirna
target
csk
sicsk
nontarget
control
ntc
cell
prolifer
assay
perform
h
posttransfect
utuntransfect
error
bar
repres
mean
sem
f
cell
pretreat
dmso
csk
inhibitor
h
infect
moi
viral
titer
infect
cultur
supernat
measur
h
pi
plaqu
assay
g
rtpcr
analysi
measur
denv
rna
total
rna
isol
h
pi
cell
treat
dmso
infect
describ
data
repres
two
experi
perform
three
replic
indic
mean
sem
p
valu
calcul
unpair
test
p
p
scientif
report
doi
denvinfect
cell
fig
denvinfect
cell
viral
replic
compart
indic
presenc
dsrna
also
posit
csk
suggest
subset
endogen
csk
local
area
activ
viral
replic
fig
observ
indic
csk
play
role
viral
replic
either
direct
interact
viral
replic
machineri
via
factor
particip
viral
rna
replic
indic
src
famili
kinas
sfk
mainli
src
fyn
involv
denv
infect
role
csk
neg
regul
sfk
signal
well
establish
surprisingli
observ
inhibit
denv
infect
cell
sfk
sirna
tyrosin
kinas
librari
screen
fig
lack
inhibit
due
insuffici
knockdown
sfk
sirna
found
reduct
level
fyn
lyn
src
sirna
transfect
cell
western
blot
fig
specul
viru
may
lack
specif
particular
sfk
member
may
util
avail
sfk
function
therefor
lack
one
sfk
may
show
effect
viru
infect
confirm
util
mous
embryon
fibroblast
syfmef
deriv
mice
lack
three
ubiquit
express
sfk
src
fyn
ye
syf
mef
src
fyn
express
restor
mef
infect
denv
viral
titer
measur
supernat
h
pi
found
denv
titer
fold
less
mef
lack
three
sfk
compar
cell
express
either
src
fyn
fig
denv
rna
level
cell
show
similar
trend
suggest
sfk
involv
prior
viral
replic
stage
fig
next
confirm
csk
affect
denv
replic
via
regul
sfk
activ
perform
csk
knockdown
sirna
syf
mef
infect
denv
measur
viral
titer
supernat
h
pi
unlik
cell
csk
knockdown
inhibitori
effect
denv
titer
syf
mef
contrari
suppress
csk
express
syf
cell
significantli
enhanc
denv
infect
fig
data
suggest
csk
express
may
also
modul
srcindepend
pathway
syf
cell
may
express
kinas
close
relat
sfk
regul
csk
overal
result
show
inhibit
denv
replic
due
csk
knockdown
link
sfk
signal
protein
kinas
pka
therefor
next
determin
phosphoryl
statu
csk
denv
infect
csk
immunoprecipit
infect
cell
lysat
h
pi
extent
csk
phosphoryl
analys
immunoblot
phosphocsk
antibodi
recogn
phosphoryl
ser
residu
csk
found
increas
phosphocsk
level
h
pi
indic
denv
infect
enhanc
phosphoryl
csk
fig
ii
next
assess
effect
inhibit
pka
denv
infect
cell
infect
denv
treat
pka
inhibitor
h
pi
viral
titer
viral
rna
level
estim
describ
earlier
inhibit
pka
led
signific
reduct
viral
titer
supernat
fig
effect
due
reduc
viral
replic
assess
reduct
viral
rna
level
fig
inhibit
pka
affect
cell
prolifer
fig
demonstr
effect
pka
inhibit
denv
replic
due
effect
csk
phosphoryl
cell
infect
denv
treat
dmso
h
pi
csk
phosphoryl
assess
h
pi
immunoprecipit
csk
cell
lysat
pka
inhibit
led
reduc
phosphoryl
csk
mockand
denvinfect
cell
expect
denv
infect
block
cell
treat
evidenc
reduc
express
dengu
nonstructur
protein
fig
result
suggest
phosphoryl
csk
pka
potenti
denv
infect
pka
activ
may
play
essenti
role
denv
replic
csk
activ
known
regul
intramolecular
interact
differ
domain
csk
domain
csk
shown
potenti
kinas
activ
csk
bind
phosphoryl
kinas
domain
specul
overexpress
csk
would
neg
affect
dengu
infect
block
sfk
signal
shown
import
denv
replic
therefor
express
wild
type
wt
csk
csk
protein
mutat
delet
would
help
us
delin
regiondomain
csk
involv
denv
replic
test
transfect
cell
plasmid
express
flagtag
csk
protein
name
wildtyp
cskwt
csk
kinas
domain
delet
kd
csk
inact
domain
csk
lack
domain
transfect
cell
infect
denv
effici
infect
transfect
condit
analyz
immunofluoresc
found
express
level
wild
type
csk
less
compar
construct
probabl
due
pleiotrop
effect
dysregul
sfk
signal
pathway
result
csk
upregul
see
supplementari
fig
nevertheless
wild
type
csk
csk
nonfunct
domain
inhibit
viru
infect
suggest
overexpress
protein
neg
effect
viru
infect
like
due
inhibit
sfk
kinas
domain
delet
domain
delet
construct
fail
show
inhibitori
effect
fig
fig
quantit
number
viru
posit
cell
untreat
cell
flagposit
cell
found
reduct
virusposit
cell
cskwt
express
number
denv
posit
cell
significantli
differ
cell
express
csk
delet
kinas
domain
domain
compar
untransfect
cell
suggest
kinas
activ
domain
csk
import
denv
infect
fig
role
tk
viral
infect
extens
studi
mani
virus
requir
activ
cellular
tk
variou
stage
infect
virus
influenza
viru
kaposi
sarcomaassoci
herpesviru
util
receptor
tk
enter
cell
virus
like
coxsackieviru
depend
activ
cytosol
tk
stage
postvir
attach
ebola
viru
shown
depend
activ
tyrosin
kinas
entri
later
stage
bud
releas
virion
essenti
role
tk
signal
viral
replic
identifi
number
studi
use
multipl
approach
pharmacolog
inhibitor
specif
tk
express
virus
harbor
mutat
tk
interact
region
use
sirna
screen
host
tk
case
virus
shown
activ
cytosol
tk
signal
pathway
modul
cellular
environ
favor
viru
replic
virus
influenc
tk
activ
either
direct
interact
viral
protein
tk
indirectli
regul
kinas
activ
mediat
modul
tk
signal
pathway
activ
antivir
innat
immun
respons
flaviviru
infect
report
earlier
addit
axl
receptor
tk
shown
mediat
cellular
entri
denv
current
studi
identifi
new
role
csk
denv
rna
replic
cell
knockdown
csk
express
sirna
show
reduc
level
viral
rna
csk
shown
partial
coloc
dsrna
suggest
csk
may
either
directli
associ
viral
replic
compart
may
part
multiprotein
complex
particip
viral
replic
found
csk
hyperphosphoryl
denv
infect
inhibit
pka
use
specif
inhibitor
block
viru
replic
suggest
crucial
role
csk
phosphoryl
pka
denv
replic
csk
activ
regul
intramolecular
interact
domain
catalyt
domain
addit
domain
also
shown
involv
dimer
csk
protein
prevent
bind
tyrosin
phosphatas
pep
domain
thu
prevent
inactiv
sfk
domain
longer
capabl
inhibit
denv
infect
clearli
indic
csk
activ
domain
play
import
role
denv
replic
src
famili
kinas
fyn
src
identifi
necessari
player
denv
rna
replic
assembl
respect
anoth
ubiquit
sfk
ye
shown
involv
later
stage
wnv
lifecycl
howev
exact
mechan
action
sfk
dengu
viru
infect
clearli
demonstr
notabl
studi
shown
role
sfk
dengu
viru
replic
assemblyegress
use
inhibitor
sfk
shown
target
sfk
studi
syf
cell
lack
three
ubiquit
express
sfk
name
src
fyn
ye
show
drastic
reduct
denv
product
suggest
kinas
essenti
denv
replic
demonstr
express
either
src
fyn
syf
cell
suffici
compens
absenc
three
sfk
suggest
lack
specif
sfk
denv
replic
also
explain
lack
effect
denv
infect
express
one
sfk
suppress
sirna
cell
studi
interestingli
previou
studi
use
sirna
screen
identifi
protein
kinas
hepat
c
viru
replicon
propag
identifi
csk
one
hit
show
csk
mediat
effect
replic
hcv
replicon
suppress
fyn
activ
whether
csk
activ
increas
denv
infect
dynam
regul
sfk
activ
differ
stage
denv
lifecycl
need
examin
suggest
csk
may
critic
attenu
sfk
activ
rather
control
basal
activ
sfk
possibl
deplet
csk
probabl
affect
attenu
sfk
signal
turn
advers
effect
denv
replic
similarli
overexpress
csk
may
also
block
sfk
signal
neg
impact
viral
replic
sfk
signal
shown
import
dengu
replic
neg
regul
sfk
wellcharacter
function
csk
howev
recent
report
deciph
consensu
sequenc
csk
phosphoryl
suggest
csk
may
phosphoryl
number
cellular
protein
immunoreceptor
tyrosinebas
inhibitori
motif
itim
platelet
endotheli
cell
adhes
molecul
sialic
acid
bind
lectinlik
also
shown
phosphoryl
csk
although
phosphoryl
requir
prior
phosphoryl
sfk
sequenti
phosphoryl
itim
propos
downregul
activ
immunoreceptor
tyrosinebas
activ
motif
itam
depend
signal
recruit
tandem
contain
tyrosin
phosphatas
addit
csk
also
known
regul
sfk
activ
recruit
tyrosin
phosphatas
would
interest
investig
role
tyrosin
phosphatas
interact
csk
denv
replic
studi
identifi
role
csk
pka
signal
mosquitoborn
flaviviru
replic
provid
new
perspect
role
sfk
signal
flaviviru
infect
effort
character
exact
role
csk
denv
replic
may
provid
novel
target
develop
antivir
dengu
diseas
cell
virus
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
mm
lglutamin
unitsml
penicillin
g
sodium
gml
streptomycin
sulfat
nonessenti
amino
acid
co
porcin
kidney
ps
cell
cell
grown
minim
essenti
medium
mem
contain
fb
earl
salt
addit
mention
syf
syfsrc
cell
atcc
syffyn
cell
describ
earlier
jev
denv
strain
use
studi
describ
previous
sirna
transfect
sirna
librari
target
human
tyrosin
kinas
gene
purchas
dharmacon
cat
transfect
perform
revers
transfect
procedur
per
manufactur
instruct
use
lipofectamin
rnaimax
reagent
life
technolog
nm
sirna
mix
optimem
life
technolog
l
lipofectamin
rnaimax
total
volum
l
plate
cell
trypsin
volum
made
contain
cell
l
antibioticfre
medium
min
incub
transfect
complex
l
cell
suspens
ad
well
sirna
transfect
perform
triplic
group
sirna
use
set
experi
knockdown
level
monitor
rtpcr
h
posttransfect
repres
sirna
set
experi
consist
observ
reduct
mrna
level
target
gene
condit
plasmid
antibodi
csk
plasmid
construct
use
studi
kind
gift
lar
csk
rabbit
antibodi
purchas
santa
cruz
biotechnolog
mous
monoclon
csk
parametr
mannwhitney
test
size
prestain
molecular
weight
marker
band
indic
b
cell
infect
cell
incub
medium
contain
pka
inhibitor
dmso
vehicl
control
viral
titer
supernat
measur
plaqu
assay
h
pi
ii
rtpcr
analysi
measur
denv
rna
total
rna
isol
h
pi
cell
infect
treat
dmso
postinfect
data
repres
least
three
experi
perform
two
replic
indic
mean
sem
p
valu
calcul
nonparametr
mannwhitney
test
iii
cell
incub
medium
contain
pka
inhibitor
dmso
vehicl
control
cell
prolifer
assay
perform
h
posttransfect
utuntr
error
bar
repres
mean
sem
c
cell
mockinfect
infect
treat
dmso
h
pi
csk
immunoprecipit
h
pi
phosphocsk
detect
western
blot
analysi
antibodi
specif
amount
total
csk
pull
immunoprecipit
shown
total
csk
cell
lysat
shown
gapdh
level
shown
load
control
size
prestain
molecular
weight
marker
band
indic
scientif
report
doi
antibodi
bd
transduct
lab
cat
rabbit
phosphocsk
pserin
antibodi
sigmaaldrich
cat
src
antibodi
epitom
cat
antidsrna
antibodi
scicon
actin
catalogu
number
antiflag
antibodi
purchas
sigmaaldrich
cat
tubulin
antibodi
purchas
development
studi
hybridoma
bank
http
dshbbiologyuiowaedu
denv
capsid
antibodi
describ
gapdh
antibodi
purchas
abcam
cat
horseradish
peroxid
hrp
conjug
igg
rais
goat
use
secondari
antibodi
santa
cruz
life
technolog
western
blot
viral
titer
real
time
pcr
western
blot
viru
growth
curv
experi
perform
cell
viral
titer
cultur
supernat
determin
plaqu
assay
cell
denv
porcin
kidney
cell
jev
describ
previous
viral
entri
assay
perform
infect
cell
pfucel
cell
collect
trypsin
h
pi
complet
medium
quantit
rna
cell
wash
pb
collect
l
trizol
reagent
life
technolog
isol
total
rna
real
time
pcr
perform
use
onestep
twostep
method
use
sybr
green
taqman
chemistri
describ
previous
immunoblot
cell
lysat
prepar
lysi
buffer
mm
triscl
mm
nacl
triton
sodium
deoxychol
sd
contain
phenylmethylsulfonyl
fluorid
pmsf
proteas
inhibitor
cocktail
pic
roch
supernat
obtain
centrifug
g
use
load
onto
sdspage
analys
western
blot
describ
previous
immunoprecipit
cell
infect
moi
pfucel
infect
cell
lysat
prepar
h
h
pi
phosphobuff
calbiochem
contain
pic
pmsf
lysat
preclear
nonspecif
antibodi
interact
incub
rabbit
igg
l
prewash
protein
bead
h
preclear
lysat
incub
polyclon
csk
antibodi
overnight
antigenantibodi
complex
pull
use
proteina
bead
detect
immunoblot
use
antibodi
sigmaaldrich
total
csk
immunoprecipit
quantit
western
blot
mous
monoclon
csk
antibodi
follow
manufactur
protocol
life
technolog
briefli
plasmid
dna
mix
optimem
separ
incub
room
temperatur
min
two
mix
incub
min
room
temperatur
mixtur
dna
lipid
ad
cell
plate
antibioticfre
media
h
media
replac
complet
media
h
posttransfect
cell
either
infect
process
immunofluoresc
immunofluoresc
cell
grown
coverslip
infect
moi
h
pi
cell
fix
chill
methanol
process
immunofluoresc
describ
previous
imag
acquir
use
olympu
fluoview
confoc
microscop
x
x
object
imag
process
background
subtract
use
fluoview
softwar
prepar
illustr
use
imag
j
softwar
nih
coloc
analysi
singl
slice
zstack
use
region
interest
show
coloc
mark
extract
pearson
correl
coeffici
extract
coloc
pixel
determin
use
fluoview
softwar
olympu
quantit
transfect
infect
effici
plasmid
transfect
denv
posit
flagposit
cell
imag
manual
count
multipl
imag
acquir
sampl
cell
prolifer
cytotox
assay
cell
prolifer
measur
use
promega
celltit
aq
ueou
one
solut
cell
prolifer
assay
kit
per
manufactur
protocol
briefli
cell
grown
well
plate
treat
dmso
h
l
aq
ueou
one
solut
ad
well
contain
l
media
incub
h
reaction
stop
ad
l
sd
supernat
dilut
pb
absorb
measur
nm
od
media
alon
aq
ueou
one
solut
use
subtract
background
cell
prolifer
assay
sirna
transfect
cell
cell
transfect
nm
indic
sirna
nontarget
control
ntc
sirna
cell
prolifer
measur
describ
h
posttransfect
cytotox
assay
perform
describ
previous
cell
treat
cell
viabil
determin
trypan
blue
stain
statist
analysi
graphpad
prism
softwar
use
graphic
represent
statist
analysi
experi
perform
two
three
replic
sampl
figur
repres
experi
perform
least
three
time
non
parametr
statist
test
perform
calcul
p
valu
